Marker for early diagnosis, distant metastasis or curative effect monitoring of non-small cell lung cancer

The invention discloses a marker for early diagnosis, distant metastasis or curative effect monitoring of non-small cell lung cancer, and relates to the field of biological detection. The marker is m6A modified RNA (Ribonucleic Acid) in peripheral blood immune cells. The invention provides a novel marker for early diagnosis, distant metastasis or curative effect monitoring of the non-small cell lung cancer, the marker can be used as an early diagnosis marker of the non-small cell lung cancer and a monitoring index of distant metastasis and curative effect of the non-small cell lung cancer, and the marker has the characteristics of good specificity and high sensitivity, and can be used as a marker for early diagnosis of the non-small cell lung cancer and a monitoring index of the distant metastasis and curative effect of the non-small cell lung cancer. The kit has a good diagnostic value for non-small cell lung cancer. 本发明公开了一种非小细胞肺癌的早期诊断、发生远处转移或疗效监测的标志物，涉及生物检测领域；该标志物为外周血免疫细胞中m6A修饰的RNA。本发明提供了一种新的非小细胞肺癌的早期诊断、发生